Dr. Mark A. Preston is a urologic surgeon at Brigham and Women’s Hospital and Associate Professor of Surgery at Harvard Medical School. Dr. Preston received his Medical Degree from the University of Ottawa in Canada, where he also completed his residency training in Urology. He completed a three-year accredited fellowship in Urologic Oncology at Massachusetts General Hospital including a Masters of Public Health from the Harvard School of Public Health with a concentration in clinical effectiveness. He is board certified in Urology.Dr. Preston’s clinical interests include urologic oncology (bladder, kidney, prostate and testicular cancer) and minimally invasive surgery. Dr. Preston’s research focuses on the epidemiology of prostate and kidney cancer risk with an emphasis on predictive biomarkers and pharmacoepidemiology. Dr. Preston is rated as an Elite provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. His top areas of expertise are Bladder Cancer, Muscle Invasive Bladder Cancer, Prostate Cancer, Cystectomy, and Prostatectomy.

Dr. Graeme Steele is The Professor Walter Morris-Hale Distinguished Chair in Urologic Oncology at Brigham and Women’s Hospital, surgical oncologist at Dana-Farber Cancer Institute, and assistant professor of medicine at Harvard Medical School. He received his medical degree from the University of the Witwatersrand and completed his internship in general surgery at Johannesburg Hospital. He completed residencies in general surgery and urology at the University of Witwatersrand Medical School in Johannesburg, South Africa, and became head of their Department of Urology Medical School.In 1995, he moved to Boston and completed his urology residency at the Harvard Urology Residency Program and received his fellowship in urology at Brigham and Women’s Hospital. Dr. Steele is board certified in urology.The author of numerous clinical publications, Dr. Steele has conducted research studies focusing on benign prostatic hyperplasia, urodynamic evaluation, bladder cancer, urinary cancer and testicular cancer. His clinical specialties include: urinary incontinence, urodynamic studies, urologic oncology and voiding dysfunction. Dr. Steele is rated as a Distinguished provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. His top areas of expertise are Muscle Invasive Bladder Cancer, Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Vasectomy, and Orchiectomy.

Dr. Mossanen is a graduate of the University of California, Los Angeles (UCLA) in Los Angeles, CA and received his medical degree from the David Geffen School of Medicine at UCLA. He also holds a Master of Public Health from the Harvard T.H. Chan School of Public Health in Boston, MA. Dr. Mossanen completed a residency in Urology from the University of Washington in Seattle, WA followed by a fellowship in Urologic Oncology in the Combined Harvard Urologic Oncology Fellowship at Massachusetts General Hospital and Brigham and Women’s Hospital. Dr. Mossanen has been board certified by the American Board of Urology since 2020.His research and clinical interests include: bladder cancer, kidney cancer, kidney masses/cysts, laparoscopic surgery, penile cancer, prostate cancer, robotic surgery, testicular cancer. Dr. Mossanen is rated as a Distinguished provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. His top areas of expertise are Bladder Cancer, Muscle Invasive Bladder Cancer, Penile Cancer, Cystectomy, and Nephrectomy.

Aria Olumi is a Urologist in Boston, Massachusetts. Dr. Olumi is rated as a Distinguished provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. His top areas of expertise are Prostate Cancer, Bladder Cancer, Urothelial Cancer, Cystectomy, and Prostatectomy.

Andrew Wagner is a Urologist in Boston, Massachusetts. Dr. Wagner is rated as a Distinguished provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. His top areas of expertise are Prostate Cancer, Renal Cell Carcinoma (RCC), Bladder Cancer, Nephrectomy, and Cystectomy.

Boris Gershman is a Urologist in Boston, Massachusetts. Dr. Gershman is rated as a Distinguished provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. His top areas of expertise are Bladder Cancer, Urothelial Cancer, Renal Cell Carcinoma (RCC), Nephrectomy, and Cystectomy.

Peter Chang is a Urologist in Boston, Massachusetts. Dr. Chang is rated as a Distinguished provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. His top areas of expertise are Prostate Cancer, Bladder Cancer, Urothelial Cancer, Prostatectomy, and Nephrectomy.

Ned Saltzman is a Urologist in Newton, Massachusetts. Dr. Saltzman is rated as a Distinguished provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. His top areas of expertise are Enlarged Prostate (BPH), Perirenal Abscess, Carbuncle, Ureteroscopy, and Prostatectomy.

Peter Steinberg is a Urologist in Chestnut Hill, Massachusetts. Dr. Steinberg is rated as an Advanced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. His top areas of expertise are Kidney Stones, Boils, Perirenal Abscess, Ureteroscopy, and Lithotripsy.

Ilana Warsofsky is a Radiologist in Chestnut Hill, Massachusetts. Dr. Warsofsky is rated as an Advanced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. Her top areas of expertise are Non-Muscle Invasive Bladder Cancer, Muscle Invasive Bladder Cancer, Chronic Cough, and Vertigo.

Dr. Michael W. McDonald is a urologic surgeon at Brigham and Women’s Hospital. He received his medical degree from Tulane University School of Medicine and completed his residency at the University of Michigan. He completed his fellowship in transplant surgery at Mayo Clinic and in urology at the University of Texas, M.D. Anderson Cancer Center. Dr. McDonald is board certified in urology.Dr. McDonald’s clinical specialties include: urinary incontinence, urologic oncology, voiding dysfunction, benign prostatic hypertrophy, male infertility, male sexual dysfunction, prostate cancer and stone disease. He is fluent in Spanish and German. Dr. Mcdonald is rated as an Advanced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. His top areas of expertise are Bladder Stones, Enlarged Prostate (BPH), Urinary Tract Infection in Children, Urinary Tract Infection (UTI), and Ureteroscopy.

Dr. James Rosoff is an associate surgeon at Brigham and Women’s Hospital. He received his Bachelor of Arts in Behavioral Neuroscience from Yale University. Dr. Rosoff graduated from Weill Cornell Medical College of Cornell University in 2006 and went on to complete his residency at New York-Presbyterian Hospital/Weill Cornell Medical Center. Following his residency, he was a Urologic Oncology fellow at the Medical University of South Carolina.   Before joining the Division of Urological Surgery at the Brigham, Dr. Rosoff was an Assistant Professor for the Department of Urology at the Yale School of Medicine, and most recently an Attending Urologic Surgeon at Hartford Healthcare, St. Vincent’s Medical Center.  Dr. Rosoff’s clinical interests include management of BPH, treatment of kidney stone disease, MRI fusion biopsy technology for the diagnosis of prostate cancer, as well as the management of testicular and scrotal conditions, urinary symptoms, erectile dysfunction, low testosterone, and bladder cancer. Dr. Rosoff is rated as an Advanced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. His top areas of expertise are Urachal Cyst, Prostate Cancer, Enlarged Prostate (BPH), Nephrectomy, and Lithotripsy.

Arthur Little is a Urologist in Jamaica Plain, Massachusetts. Dr. Little is rated as an Advanced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Enlarged Prostate (BPH), Muscle Invasive Bladder Cancer, and Ureteroscopy.

Meredith Faggen is a Hematologist Oncology specialist and a Hematologist in Boston, Massachusetts. Dr. Faggen is rated as an Experienced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. Her top areas of expertise are Angiosarcoma, Inflammatory Breast Cancer, Paget Disease of the Breast, and Breast Cancer. Dr. Faggen is currently accepting new patients.

Neil Martin is a Radiation Oncologist in Boston, Massachusetts. Dr. Martin is rated as an Advanced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Pancreatic Cancer, Prostatectomy, and Orchiectomy.

Dmitry Rabkin is a Radiologist in Boston, Massachusetts. Dr. Rabkin is rated as an Advanced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. His top areas of expertise are Non-Muscle Invasive Bladder Cancer, Muscle Invasive Bladder Cancer, Inflammatory Breast Cancer, Breast Cancer, and Liver Embolization.

Michael Stecker is a Radiologist in Boston, Massachusetts. Dr. Stecker is rated as an Advanced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. His top areas of expertise are Gallbladder Adenocarcinoma, Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Retroperitoneal Fibrosis, and Liver Embolization.

Kent Mouw is a Radiation Oncologist in Boston, Massachusetts. Dr. Mouw is rated as an Advanced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. His top areas of expertise are Muscle Invasive Bladder Cancer, Prostate Cancer, Upper Tract Urothelial Carcinoma (UTUC), Prostatectomy, and Orchiectomy.

Andrea Bullock is an Internal Medicine provider in Boston, Massachusetts. Dr. Bullock is rated as an Advanced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. Her top areas of expertise are Pancreatic Ductal Adenocarcinoma, Gallbladder Adenocarcinoma, Non-Muscle Invasive Bladder Cancer, Pancreaticoduodenectomy, and Gamma Knife Radiosurgery.

David Mcdermott is an Internal Medicine specialist and an Oncologist in Boston, Massachusetts. Dr. Mcdermott is rated as an Advanced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. His top areas of expertise are Renal Cell Carcinoma (RCC), Melanoma, Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, and Nephrectomy.